Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 15th, there was short interest totalling 4,300 shares, a growth of 207.1% from the December 31st total of 1,400 shares. Based on an average trading volume of 11,200 shares, the days-to-cover ratio is currently 0.4 days.
Invesco Nasdaq Biotechnology ETF Stock Performance
Shares of NASDAQ IBBQ opened at $22.65 on Friday. The company has a market cap of $40.09 million, a PE ratio of 17.39 and a beta of 0.61. The firm’s 50 day moving average price is $22.20 and its 200-day moving average price is $23.25. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.14 and a 52-week high of $24.84.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
The firm also recently announced a dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 23rd were issued a $0.0619 dividend. The ex-dividend date was Monday, December 23rd.
Institutional Inflows and Outflows
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Recommended Stories
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Turnaround Stocks in the Early Innings With More Upside to Come
- 3 Warren Buffett Stocks to Buy Now
- Whirlpool: Buy This High-Yielding Value Before It Spins Higher
- What is the MACD Indicator and How to Use it in Your Trading
- Commvault Systems: Share Price Primed to Vault Higher in 2025
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.